2025 年 07 月 24 日 智源和 Kimi K2 测试成绩优秀， OpenAI 正式推 出通用智能体 推荐(维持) 投资要点 分析师：宝幼琛 S1050521110002 baoyc@cfsc.com.cn 行业相对表现 | 表现 | 1M | 3M | 12M | | --- | --- | --- | --- | | 计算机(申万) | 6.0 | 12.0 | 63.4 | | 沪深 300 | 5.5 | 8.9 | 20.5 | 市场表现 相关研究 1、《计算机行业点评报告：Kimi： Researcher、K2 双线突破，强化学 习革新与开源智能的双擎驱动》 2025-07-21 2、《计算机行业周报：Grok4 屠榜 验证 Scalinglaw 有效，高德地图推 出小高智能体》2025-07-16 3、《计算机行业周报：谷歌发布全 新多模态大模型 Gemma3n，阿里达摩 院发布医疗 AI 模型 DAMOGRAPE》 2025-06-30 7 月 18 日，OpenAI 于新产品直播中发布了全新的 ChatGPT Agent，它实现了通用智能体（Agent）能力的关键升级。与 以往的基础 ...

Core Viewpoint - The article highlights the active cash dividend distribution by listed companies in the context of regulatory encouragement, with a total of 3,679 companies proposing distribution plans for the 2024 fiscal year, including cash dividends totaling 1.64 trillion yuan [1][2]. Group 1: Dividend Distribution - A total of 3,674 companies included cash dividends in their 2024 distribution plans, with a cumulative cash payout of 1.64 trillion yuan [1]. - There are 346 companies that included stock transfers in their distribution plans for 2024 [1]. - The article emphasizes two important dates for investors focused on dividends: the ex-dividend date and the record date, with 3,398 companies having already implemented their distribution plans [1]. Group 2: Companies with Dividend Plans - Among the 13 companies with record dates today, 9 companies have a cash dividend of 1 yuan (after tax) or more per 10 shares, with Weike Technology offering the highest at 6.00 yuan per 10 shares [1][2]. - The companies listed for dividend distribution include: - Weike Technology: 6.00 yuan per 10 shares, latest closing price 83.66 yuan, 5-day increase 30.35% [2]. - Zhejiang Medicine: 3.70 yuan per 10 shares, latest closing price 15.51 yuan, 5-day increase 1.31% [2]. - Hangzhou Bank: 2.80 yuan per 10 shares, latest closing price 16.85 yuan, 5-day decrease 2.94% [2].

Market Overview - A-shares maintained a narrow fluctuation on July 16, with the Shanghai Composite Index closing at 3503.78 points, down 0.03% [1] - The Shenzhen Component Index and the ChiNext Index both fell by 0.22% to 10720.81 points and 2230.19 points, respectively [1] - The total trading volume in the Shanghai and Shenzhen markets was 146.19 billion yuan, a decrease of over 170 billion yuan from the previous day [1] Sector Performance - Financial stocks collectively declined, while the steel, non-ferrous metals, and coal sectors showed weakness [1] - The automotive supply chain stocks surged, with companies like Rongtai Co., Fuda Co., and Zhejiang Rongtai hitting the daily limit [1] - The innovative drug concept saw significant activity, with stocks like Guosheng Tang and Iwu Biotech rising approximately 16% [5][6] - The humanoid robot concept remained hot, with companies like Shangwei New Materials achieving a six-day limit increase [2][4] Notable Company Movements - Huadian New Energy, which debuted on the Shanghai main board, closed up 125.8%, reaching a market value of over 300 billion yuan at one point [1] - Weiyali, a Hong Kong-based electronic component distributor, saw its stock surge by 288% upon resuming trading, with an intraday increase exceeding 900% [1] Humanoid Robot Sector Insights - The humanoid robot industry is in its early stages, with significant growth expected in the next 3 to 5 years across various applications [4] - The current phase is described as the "dawn" of humanoid robot industrialization, with mass production and large-scale application becoming feasible [4] - Cost reduction is crucial for the widespread adoption of humanoid robots, and companies that master core component technologies are recommended for investment [4] Innovative Drug Sector Insights - The innovative drug sector experienced strong gains, with several companies hitting the daily limit [5][6] - The recent launch of the 11th batch of national drug centralized procurement is expected to impact the market, focusing on mature "old drugs" rather than innovative drugs [7] - The introduction of measures to support the high-quality development of innovative drugs indicates a growing role for commercial insurance in the healthcare system [7] Pet Economy Sector Insights - The pet economy concept gained traction, with companies like Weike Technology rising over 10% [8] - The pet food sector is viewed as a growing market with significant long-term growth potential, particularly for domestic brands [8]

证券代码：301196 证券简称：唯科科技 公告编号：2025-036 厦门唯科模塑科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 厦门唯科模塑科技股份有限公司（以下简称"公司"）2024 年度利润分配 方案已获 2025 年 5 月 30 日召开的公司 2024 年度股东大会审议通过，现将分红 派息事宜公告如下： 一、股东大会审议通过利润分配方案情况 分配方案：公司拟以实施权益分派股权登记日登记的公司股份总数扣减公司回购 专用证券账户中的股份为基数，向全体股东按每 10 股派发现金股利 6 元（含税）， 预计派发现金股利 74,880,000 元（含税）；不送红股，不进行资本公积金转增 股本。在利润分配方案披露日至实施权益分配股权登记日期间，因新增股份上市、 股权激励授予或行权、可转债转股、股份回购等事项导致公司股本发生变动的， 公司将按照分配比例不变的原则对分配总额进行调整。 划首次授予部分第二个归属期归属事宜，回购专用证券账户的股份数量由 公司总股本变更为 125,256,497 股。公司按照分配比例不变的原则对分配总额进 行调整，即以 ...

证券代码：301196 证券简称：唯科科技 公告编号：2025-036 厦门唯科模塑科技股份有限公司 2024 年度分红派息实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 厦门唯科模塑科技股份有限公司（以下简称"公司"）2024 年度利润分配 方案已获 2025 年 5 月 30 日召开的公司 2024 年度股东大会审议通过，现将分红 派息事宜公告如下： 一、股东大会审议通过利润分配方案情况 1、2025 年 5 月 30 日，公司 2024 年度股东大会审议通过的 2024 年度利润 分配方案：公司拟以实施权益分派股权登记日登记的公司股份总数扣减公司回购 专用证券账户中的股份为基数，向全体股东按每10股派发现金股利6元（含税）， 预计派发现金股利 74,880,000 元（含税）；不送红股，不进行资本公积金转增 股本。在利润分配方案披露日至实施权益分配股权登记日期间，因新增股份上市、 股权激励授予或行权、可转债转股、股份回购等事项导致公司股本发生变动的， 公司将按照分配比例不变的原则对分配总额进行调整。 三、分红派息日期 2、自利润分配方案披露至实 ...

Group 1: Core Insights - A-share companies are experiencing significant overseas expansion, with notable achievements in infrastructure, biomedicine, and equipment manufacturing, leading to large overseas orders [2][3] - The shift in Chinese enterprises' overseas strategy is moving from cost-driven to innovation-driven, leveraging advanced supply chains, international talent, and digital technologies [2] Group 2: Large Orders and Competitive Strength - A-share companies have secured substantial overseas contracts, particularly in the infrastructure sector, with notable projects including a $1.6 billion contract for a gas processing plant in Iraq and contracts totaling approximately 5.34 billion yuan for the China-Kyrgyzstan-Uzbekistan railway [3][4] - In the biomedicine sector, companies like Rongchang Bio are accelerating internationalization, exemplified by a licensing agreement with Vor Bio worth up to $4.1 billion [4] - Equipment manufacturing firms are also making strides, with agreements such as a $406 million contract for a conveyor system in Guinea, enhancing their international market presence [4] Group 3: Accelerated Overseas Capacity Layout - Several A-share companies are intensifying their overseas production capacity, viewing local production as a key driver for global competitiveness [6] - Companies like Linglong Tire are investing $1.193 billion in a production base in Brazil, aiming for an annual output of 14.7 million high-performance tires [6] - Other firms, such as North Special Technology and Zhongke Electric, are also establishing production bases in Thailand and Oman, respectively, to enhance their global supply chain [7] Group 4: Rising Trend of Overseas Mergers and Acquisitions - The number of disclosed overseas mergers and acquisitions by A-share companies has surpassed 60 in the first half of the year, with a focus on electronics, automotive parts, and machinery [9] - Companies are pursuing overseas acquisitions to enter emerging markets and enhance their technological capabilities, as seen with Dongshan Precision's dual acquisitions in the optical communication sector [9][10] - The strategy of overseas mergers and acquisitions is aimed at resource and market integration, with firms like Luoyang Molybdenum consolidating their overseas mineral resource reserves [10]

国金证券股份有限公司 中国证监会 2021 年 12 月 1 日核发了《关于同意厦门唯科模塑科技股份有限 公司首次公开发行股票注册的批复》（证监许可[2021]3798 号），同意公司首次公 开发行股票的注册申请。公司首次公开发行人民币普通股（A 股）股票 3,120 万 股，并于 2022 年 1 月 11 日在深圳证券交易所创业板上市。 公司首次公开发行前总股本为 93,600,000 股，首次公开发行后总股本为 124,800,000 股，其中：无流通限制及锁定安排的股票数量为 29,588,676 股，占 发行后总股本的比例为 23.71%，有流通限制及锁定安排的股票数量为 95,211,324 股，占发行后总股本的比例为 76.29%。 2022 年 7 月 11 日，公司首次公开发行网下配售限售股上市流通，股份数量 为 1,611,324 股，占当时公司总股本的 1.29%。2023 年 1 月 11 日，公司部分首次 公开发行前已发行股份上市流通，股份数量为 5,975,000 股，占当时公司总股本 的 4.79%。2023 年 7 月 11 日，公司部分首次公开发行前已发行股份上市流通， 股份 ...

证券代码：301196 证券简称：唯科科技 公告编号：2025-035 厦门唯科模塑科技股份有限公司 关于部分首次公开发行前已发行股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 1、本次解除限售的股份为厦门唯科模塑科技股份有限公司（以下简称"公 司"或"发行人"）部分首次公开发行前已发行股份； 2、本次解除限售股东户数共计 2 户，解除限售股份的数量为 56,900,000 股，占公司总股本的 45.43%，限售期为自公司首次公开发行并上市之日起 42 个 月（含自动延长锁定期 6 个月）。 3、本次解除限售的股份上市流通日期为 2025 年 7 月 11 日（星期五）。 一、首次公开发行前已发行股份概况 中国证监会 2021 年 12 月 1 日核发了《关于同意厦门唯科模塑科技股份有限 公司首次公开发行股票注册的批复》（证监许可[2021]3798 号），同意公司首 次公开发行股票的注册申请。公司首次公开发行人民币普通股（A 股）股票 3,120 万股，并于 2022 年 1 月 11 日在深圳证券交易所创业板上市。 公司首次公开发 ...

Group 1 - The establishment of the "American Party" by Elon Musk is seen as a response to the current political landscape, with Musk claiming the country is in a state of a single-party system due to waste and corruption [2][33] - Musk's political ambitions may face significant challenges, as he is unlikely to secure any electoral votes in upcoming elections [33] Group 2 - The Chinese government has implemented measures targeting medical devices imported from the EU, effective from July 6, 2025, which will affect procurement processes for medical equipment [3][5] - The measures specifically exclude products produced by European-funded enterprises in China, indicating a focus on imported goods rather than domestic production [5] Group 3 - The Chinese government has launched a plan to enhance the home service industry, with 14 specific tasks aimed at improving quality and expanding capacity, contributing to rural revitalization [6] - The plan includes measures to ensure employment security for rural laborers in the home service sector and improve their access to public services [6] Group 4 - The State-owned Assets Supervision and Administration Commission (SASAC) has issued guidelines to promote brand building among central enterprises, aiming for significant improvements in brand value by 2030 and 2035 [8] - The initiative emphasizes the importance of brand influence and competitiveness in the global market [8] Group 5 - The Hong Kong stock market has seen a significant increase in IPO fundraising, with over HKD 107 billion raised in the first half of the year, marking a 22% increase compared to the previous year [14] - The surge in IPO activity is primarily driven by investor interest in technology stocks [14] Group 6 - The domestic weight loss drug market is experiencing a shift with the introduction of the domestic GLP-1 weight loss drug, which may lead to increased competition for global giants like Novo Nordisk and Eli Lilly [34] - The pricing of weight loss drugs in China is currently high, but the entry of more products could lead to price reductions and potential inclusion in health insurance [34]

Core Insights - A total of 50 companies will have their restricted shares unlocked next week, from July 7 to July 11, with a total of 1.364 billion shares being released, amounting to a market value of 37.619 billion yuan based on the closing price on July 4 [1] Summary by Category Unlocking Schedule - The peak unlocking day is July 7, with 24 companies releasing shares worth a total of 19.109 billion yuan, accounting for 50.79% of the total unlocking value for the week [1] Companies with Highest Unlocking Value - The companies with the highest unlocking market value are: - Lingyun Guang: 5.952 billion yuan - Haohua Technology: 4.263 billion yuan - Weike Technology: 3.636 billion yuan [1] Companies with Highest Unlocking Volume - The companies with the highest number of shares being unlocked are: - Lingyun Guang: 224 million shares - Haohua Technology: 161 million shares - Anda Technology: 140 million shares [1]